Genetic markers of diffuse toxic goiter

Long -Term Outcome Therapy of Toxic Diffuse Goiter in Tehran

SUMMARY In order to evaluate the long-ter m effects of antithyroids and ahlative therapy on patients with toxic diffuse goiter (TDG) in an iodine deficient region, 206 patients were studied in Tehran. Hyperthyroidism recurred in 50%, of 80 patients treated with Methimazole (MMI), from one week to 48 months after cessation of therapy. Another 40 patients remained in remission. Of 102 patients t...

Iodinating activity of thyroid tissue in toxic diffuse goiter.

Thyroid tissue obtained from 12 patients with Graves' disease and treated with thionamide drugs for 3-7 mo before subtotal thyroidectomy, from 12 patients with Graves' disease, similarly treated, and given 50 mug of triiodothyronine (T3) for 10 days before surgery, and from 12 euthyroid patients with solitary cold nodules was investigated to compare in vitro iodination of thyroglobulin in toxic...

[Clinical biochemical and x-ray signs of a skeletal lesion in diffuse toxic goiter in children].

Direct Cost of Diffuse Toxic Goiter and Its Complications In Ukraine.

References Conclusion Methods Nowadays thyroid disease found in 50% of the adult population and 80% of the elderly population of Ukraine [1]. Growing prevalence of endocrine system disease (+9.11%) is an important medical and social problem in Ukraine. During the period 2006-2010 there was increase in the proportion of endocrine disease in total disease prevalence of 4.39% in 2006 to 4.43% in 2...

Comparison of Two Propylthiouracil Preparations in Treatment of Toxic Goiter

In order to compare the effect of propylthiouracil (PTU) of Iran Hormone Co. and that of Dr. Herbrand KG, Germany, 28 patients with toxic goiter entered this study. Each patient received 200 mg PTU daily for the first 4 weeks and 50 mg daily thereafter. 17 patients received PTU from Iran Hormone (group 1) and 111 took PTU from Germany (group 2). T4, T3 and TSH by RIA and resine T3, uptake were ...